Neurocrine Biosciences Inc
(STU:NB3)
€
153.15
-1.9 (-1.23%)
Market Cap: 15.37 Bil
Enterprise Value: 14.57 Bil
PE Ratio: 26.83
PB Ratio: 5.14
GF Score: 93/100 Neurocrine Biosciences Inc at Leerink Global Healthcare Conference Transcript
Mar 09, 2026 / 12:40PM GMT
Release Date Price:
€111.75
(+1.78%)
Marc Goodman
Leerink Partners LLC - Analyst
Thank you very much for joining us. Matt, I'll give you a chance just to make an opening comment maybe not too long, but just kind of set the stage.
Matthew Abernethy
Neurocrine Biosciences Inc - Chief Financial Officer
I'll try to run out the clock if that's okay. And we'll pivot a little bit throughout this presentation. How about that, Marc? We will be making forward-looking statements. So we'll direct you to our latest SEC filings for the related risk factors and uncertainties associated with our company and then also our industry.
Now that we have that fun fact behind us, we're at a great spot, Marc. We had -- how long was that dinner last night? About two hours?
Marc Goodman
Leerink Partners LLC - Analyst
Yeah, because they didn't serve the food very quickly.
Matthew Abernethy
Neurocrine Biosciences Inc - Chief Financial Officer
They were still catching the salmon. But to be at a spot where you have 2
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot